Jump to Main Content

2026 Highlights of ASH® in the Mediterranean, Middle East, and North Africa

Highlights of ASH in the Mediterranean, Middle East, and North Africa


About Highlights of ASH in the Mediterranean, Middle East, and North Africa

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

Blood icon

Explore a program that covers the latest and most influential topics in hematology curated from the premier science presented at the ASH annual meeting.

icon for engage interaction-an avatar looking at the screen

Actively engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with speakers, exhibitors, and peers in a close-knit setting.

Community Connection Icon

Connect with a community of individuals who share common goals and hold a mutual appreciation for the scientific advancements.

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Turkish Society of Hematology.

Program Co-Chairs

The Program Co-Chairs for the Highlights of ASH in the Mediterranean, Middle East, and North Africa are:

  • Turkish Society of Hematology Program Co-Chairs
    • Dr. Muhlis Cem Ar 
    • Dr. Sule Cangül Unal
  • American Society of Hematology Program Co-Chairs
    • Dr. John Molina
    • Dr. Rachel P. Rosovsky

Program Schedule

8:00 a.m. - 8:45 a.m.  Registration and Exhibits Open 
8:45 a.m. - 9:00 a.m. Welcome & Introduction
9:00 a.m. - 9:30 a.m. Immune Cytopenias

Anem Waheed, MD, MPH
Weill Cornell Medicine
New York, NY
9:30 a.m. - 10:15 a.m. Hemoglobinopathies & Red Blood Cell Disorders

Lydia Pecker, MD
John Hopkins Medicine
Baltimore, MD

Sule Unal Cangül, MD
Hacettepe University
Ankara, Turkey
10:15 a.m. - 10:45 a.m. Panel Discussion
10:45 a.m. - 11:15 a.m. Coffee Break in the Exhibit Hall
11:15 a.m. - 12:30 p.m. Tumor Board: Acute Myeloid Leukemia

Ivana Gojo, MD
John Hopkins Medical Center
Baltimore, MD

Jessica Altman, MD
Northwestern Medicine
Chicago, IL

Maria Teresa Voso, MD
University of Rome
Rome, Italy

John Molina, MD
Cleveland Clinic
Cleveland, OH
12:30 p.m. - 1:30 p.m. Lunch in the Exhibit Hall 
1:30 p.m. - 2:00 p.m. Transplant

Robert Negrin, MD
Stanford University
Stanford, California
2:00 p.m. - 2:30 p.m. Plasma Cell Disorders and Myeloma

Rahul Banerjee, MD, FACP
Fred Hutchinson Cancer Center
Seattle, WA
2:30 p.m. - 3:00 p.m. Panel Discussion
3:00 p.m. - 3:30 p.m. Coffee Break in the Exhibit Hall
3:30 p.m. - 4:00 p.m. Bleeding Disorders

Guy Young, MD
University of Southern California
Los Angeles, CA
4:00 p.m. - 4:45 p.m. Women's Health

Beverly Hunt, MD
Guy's and St. Thomas' NHS Foundation Trust
London

Ali Taher MD, PhD, FRCP
American University of Beirut
Beirut, Lebanon
4:45 p.m. - 5:15 p.m. Panel Discussion
5:15 p.m. Highlights of ASH® Day 1 Program Adjournment
8:45 a.m. - 9:00 a.m. Welcome & Introduction
9:00 a.m. - 9:30 a.m. Aggressive Lymphoma

Paolo Caimi, MD
Cleveland Clinic
Cleveland, OH
9:30 a.m. - 10:00 a.m. Indolent Lymphoma and Chronic Lymphocytic Leukemia

Tanya Siddiqi, MD
City of Hope
Irvine, CA
10:00 a.m. - 10:30 a.m. Panel Discussion 
10:30 a.m. - 11:00 a.m. Coffee Break in the Exhibit Hall
11:00 a.m. - 12:15 p.m. Case-Based Presentation: Thrombosis

Rachel Rosovsky, MD, MPH
Massachusetts General Hospital
Boston, Massachusetts

Scott C. Woller, MD
University of Utah
Salt Lake City, UT

Reyhan Diz-Kucukkaya, MD
Istanbul Bilim University
Istanbul, Turkey
12:15 p.m. - 1:30 p.m.  Lunch in the Exhibit Hall (All Attendees) 
Luch with the Experts (Ticketed) 
1:30 p.m. - 2:00 p.m. Acute Lymphoblastic Leukemia

John Molina, MD
Cleveland Clinic
Cleveland, OH
2:00 p.m. - 2:30 p.m. Myelodysplastic Syndromes and Myeloproliferative Neoplasms

David Sallman, MD
Moffitt Cancer Center
Tampa, FL
2:30 p.m. - 3:00 p.m. Panel Discussion 
3:00 p.m. - 3:30 p.m. Coffee Break in the Exhibit Hall
3:30 p.m. - 4:00 p.m. Pediatric Hematologic Malignancies 

Adam Lamble, MD
Seattle Children's Hospital
Seattle, WA
4:00 p.m. - 4:30 p.m. Artificial Intelligence and Informatics in Hematology Practice Improvement

Amar Kelkar, MD
Dana-Farber Cancer Institute
Boston, MA
4:30 p.m. - 5:00 p.m. Panel Discussion
5:00 p.m. Highlights of ASH in the Mediterranean, Middle East, and North Africa Adjournment